65 related articles for article (PubMed ID: 17878488)
21. [Systemic chemotherapy for unresectable pancreatic cancer].
Naruge D; Nagashima F; Furuse J
Nihon Rinsho; 2015 Mar; 73 Suppl 3():148-51. PubMed ID: 25857004
[No Abstract] [Full Text] [Related]
22. [Pancreatic carcinoma].
Okamoto T; Onda S
Nihon Rinsho; 2012 Nov; 70 Suppl 8():463-7. PubMed ID: 23513884
[No Abstract] [Full Text] [Related]
23. Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials.
Zhang Z; Song J; Xie C; Pan J; Lu W; Liu M
AAPS J; 2021 Feb; 23(2):29. PubMed ID: 33580411
[TBL] [Abstract][Full Text] [Related]
24. 14th World Congress on Gastrointestinal Cancer.
Brierley R
Lancet Oncol; 2012 Aug; 13(8):768. PubMed ID: 23024990
[No Abstract] [Full Text] [Related]
25. [Preoperative chemoradiation for pancreatic cancer].
Nakamura S
Nihon Rinsho; 2015 Mar; 73 Suppl 3():159-62. PubMed ID: 25857006
[No Abstract] [Full Text] [Related]
26. FOLFIRINOX: desert, oasis, or mirage?
Ferrone CR
Ann Surg Oncol; 2015 Apr; 22(4):1059-60. PubMed ID: 25490873
[No Abstract] [Full Text] [Related]
27. The development of multi-kinase inhibitors as pancreatic cancer therapeutics.
Dent P; Poklepovic A; Booth L; Hancock JF
Anticancer Drugs; 2021 Sep; 32(8):779-785. PubMed ID: 34397447
[TBL] [Abstract][Full Text] [Related]
28. [Pancreatic cancer: Roche versus the European Agency of Drugs].
Nau JY
Rev Med Suisse; 2006 Aug; 2(76):1937. PubMed ID: 16972545
[No Abstract] [Full Text] [Related]
29. Outcomes when cancer treatment is delivered on, or off, a clinical trial: implications for generalizability of study results.
Markman M
Oncology; 2011; 81(3-4):141-2. PubMed ID: 22024941
[No Abstract] [Full Text] [Related]
30. Re: Generalizability of trial results to elderly medicare patients with advanced solid tumors.
Mol L; Koopman M; Ottevanger PB; Punt CJ
J Natl Cancer Inst; 2015 Jun; 107(6):djv104. PubMed ID: 25952033
[No Abstract] [Full Text] [Related]
31. Chemotherapy of pancreatic cancer in patients with poor performance.
Schulz D; Algül H
Chin Clin Oncol; 2019 Oct; 8(S1):S22. PubMed ID: 31500430
[No Abstract] [Full Text] [Related]
32. Small steps can lead to substantial breakthroughs: moving the therapeutic needle forward in pancreatic cancer.
Pathak P; Weekes C; Wo JY
Lancet Oncol; 2024 Jul; 25(7):824-825. PubMed ID: 38834088
[No Abstract] [Full Text] [Related]
33. Allelic ratio of KRAS mutations in pancreatic cancer.
Lennerz JK; Stenzinger A
Oncologist; 2015 Apr; 20(4):e8-9. PubMed ID: 25777349
[No Abstract] [Full Text] [Related]
34. How should pain be controlled in clinical trials for pancreatic cancer?
Sasako M
Jpn J Clin Oncol; 1996 Oct; 26(5):391. PubMed ID: 8895683
[No Abstract] [Full Text] [Related]
35. Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective.
Meyer RM; Stanton HA; Parulekar WR; Saad F
Can Urol Assoc J; 2011 Dec; 5(6):379-81. PubMed ID: 22154628
[No Abstract] [Full Text] [Related]
36. Erlotinib in pancreatic cancer patients: do we need more information from the NCIC CTG trial?
Mandalà M; Moro C; Labianca R; Ferretti G
J Clin Oncol; 2007 Sep; 25(27):4320-1; author reply 4321-2. PubMed ID: 17878488
[No Abstract] [Full Text] [Related]
37. Erlotinib: success of a molecularly targeted agent for the treatment of advanced pancreatic cancer.
Welch SA; Moore MJ
Future Oncol; 2007 Jun; 3(3):247-54. PubMed ID: 17547518
[TBL] [Abstract][Full Text] [Related]
38. First-line erlotinib inferior to chemo in advanced lung cancer.
Oncology (Williston Park); 2012 Oct; 26(10):930-1. PubMed ID: 23176004
[No Abstract] [Full Text] [Related]
39. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
Lilenbaum R; Axelrod R; Thomas S; Dowlati A; Seigel L; Albert D; Witt K; Botkin D
J Clin Oncol; 2008 Feb; 26(6):863-9. PubMed ID: 18281658
[TBL] [Abstract][Full Text] [Related]
40. TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
Herbst RS; Prager D; Hermann R; Fehrenbacher L; Johnson BE; Sandler A; Kris MG; Tran HT; Klein P; Li X; Ramies D; Johnson DH; Miller VA;
J Clin Oncol; 2005 Sep; 23(25):5892-9. PubMed ID: 16043829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
